Related Experiment Videos

[BCG vaccination of the newborn infant with the 131 Copenhagen strain]

Klinische Padiatrie
|July 1, 1986
PubMed

Insights

BCG vaccination in infants showed a 0.3% complication rate for suppurating regional lymphadenitis. The study confirmed high tuberculin conversion rates, indicating vaccine effectiveness, with some dependence on vaccine concentration.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Context:

  • Prospective study conducted from October 1, 1979, to September 30, 1981.
  • Focus on side-effects of Bacillus Calmette-Guérin (BCG) inoculation in infants.
  • Collaboration with pediatricians, public health authorities, and obstetric departments in Duisburg, Essen, and Mülheim.

Purpose:

  • To evaluate the side-effects of BCG inoculation, specifically suppurating regional lymphadenitis.
  • To assess the tuberculin conversion ratio following BCG vaccination.
  • To investigate the relationship between vaccine concentration and outcomes.

Summary:

  • 21,294 infants (89% of live births) received BCG vaccination using the Copenhagen 1331 strain.
  • A complication rate of 0.3% was observed for suppurating regional lymphadenitis (66 cases).
  • High tuberculin conversion rates were documented: 84% positive on initial test, 98.4% positive after a second test if needed.

Impact:

  • The study demonstrates a low incidence of serious side-effects from BCG vaccination.
  • High conversion rates indicate BCG's efficacy in inducing tuberculin-positive reactions.
  • Vaccine concentration influences both conversion rates and local ulceration incidence.

Related Concept Videos